RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic Test
Short Name: RET Gene Selective Sequencing
Also known as: RET Gene Mutation Analysis, RET Exon 5,8,10,11,13-16 Sequencing, RET NGS Panel
RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically delivered within 3 to 4 weeks after the sample reaches the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SHAILAJA RAGHUNATH MURDESHWAR
Consultant Physician · Reg: 8052
Last updated: September 7, 2026
Overview
The purpose of this test is to identify pathogenic variants in the RET gene that predispose individuals to hereditary cancer syndromes, particularly MEN2 and familial MTC. It aids in confirming clinical diagnoses, guiding prophylactic thyroidectomy decisions, and enabling cascade screening of at-risk family members.
- Test Code
- 6021
- CPT Code
- 81479
- ICD Code
- Z13.89
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are typically delivered within 3 to 4 weeks after the sample reaches the laboratory.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Genetic testing has revolutionized the field of medicine, providing clinicians with valuable insights into an individual's health and potential risk for certain diseases. One such test is the RET gene selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS genetic DNA test. This test helps in the diagnosis of certain genetic disorders associated with the RET gene. In this blog, we will discuss the RET gene, its associated disorders, and the importance of the RET gene selective sequencing test.
The RET Gene
The RET gene is located on chromosome 10 and provides instructions for making a protein called the RET receptor tyrosine kinase. The RET protein plays an important role in the development and maintenance of nerve cells, especially those in the enteric nervous system, which controls the movement of food through the digestive tract.
Disorders Associated with RET Gene Mutations
Several genetic disorders are associated with mutations in the RET gene, including:
- Multiple Endocrine Neoplasia Type 2 (MEN2)
- Medullary Thyroid Carcinoma (MTC)
- Hirschsprung Disease (HD)
- Phaeochromocytoma (PCC)
MEN2 is a rare genetic disorder that affects the endocrine system, causing tumors to develop in the thyroid gland and adrenal glands. MTC is a type of thyroid cancer that arises from the parafollicular cells, which produce a hormone called calcitonin. HD is a congenital disorder that affects the nerve cells in the large intestine, causing problems with bowel movements. PCC is a rare tumor that develops in the adrenal glands, causing overproduction of adrenaline and other hormones.
The RET Gene Selective Sequencing Test
The RET gene selective sequencing test is a genetic test that analyzes specific regions of the RET gene to detect mutations that may be associated with the above-mentioned disorders. The test analyzes exons 5, 8, 10, 11, and 13-16 of the RET gene using Next-Generation Sequencing (NGS) technology. NGS is a high-throughput sequencing method that enables the analysis of millions of DNA sequences simultaneously.
Symptoms and Diagnosis
The symptoms of disorders associated with RET gene mutations vary depending on the disorder. In MEN2, symptoms may include a lump or swelling in the neck, hoarseness, difficulty breathing, and diarrhea. In MTC, symptoms may include a lump or swelling in the neck, difficulty swallowing, hoarseness, and cough. In HD, symptoms may include constipation, abdominal swelling, and vomiting. In PCC, symptoms may include high blood pressure, headaches, sweating, and palpitations.
Diagnosis of these disorders usually involves a combination of physical examination, imaging tests, and genetic testing. The RET gene selective sequencing test can help confirm a diagnosis and provide valuable information for treatment and management.
Cost of the RET Gene Selective Sequencing Test
The cost of the RET gene selective sequencing test in India is INR 20,000. The test is available at DNA Labs India, a leading provider of genetic testing services in the country. DNA Labs India uses state-of-the-art NGS technology to ensure accurate and reliable results.
Conclusion
The RET gene selective sequencing test is a valuable tool for the diagnosis of genetic disorders associated with the RET gene. The test can provide important information for treatment and management of these disorders. If you or someone you know is experiencing symptoms associated with these disorders, it is important to seek medical attention and consider genetic testing. Contact DNA Labs India to learn more about the RET gene selective sequencing test and other genetic testing services.
Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic DNA Test
Sample Collection
No special preparation is required. However, a genetic counseling session is recommended to discuss the implications of the test. Please bring any relevant medical records and family history information.
Method: Venipuncture or Fingerstick
Laboratory Analysis
A blood sample will be drawn from a vein in your arm. If using FTA card, a fingerstick blood drop will be collected. The procedure is quick and minimally invasive.
Report Delivery
You can resume normal activities immediately. There are no restrictions. The sample will be sent to the laboratory for analysis.
Timeline: Reports are typically delivered within 3 to 4 weeks after the sample reaches the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify pathogenic variants in the RET gene that predispose individuals to hereditary cancer syndromes, particularly MEN2 and familial MTC. It aids in confirming clinical diagnoses, guiding prophylactic thyroidectomy decisions, and enabling cascade screening of at-risk family members.
How to Prepare
- Ensure the sample is collected in an EDTA vacutainer or on an FTA card as provided.
- Label the sample with patient's full name, date of birth, and collection date.
- If using FTA card, allow the blood spot to air dry completely before sealing.
- Transport the sample at ambient temperature; avoid extreme heat or cold.
- For extracted DNA, provide at least 1 µg of high-quality DNA in a sterile tube.
Doctor's Notes
Reviewed by Dr SHAILAJA RAGHUNATH MURDESHWAR — MBBS, MD (General Medicine) · Reg. No. 8052
"RET gene mutations are critical in hereditary cancer syndromes. Early detection through targeted sequencing enables proactive management and family screening."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood sample
- Insufficient sample volume
- Improperly labeled sample
- Sample exposed to extreme temperatures
- Sample received after prolonged transit time (>7 days) without proper storage
Understanding Your Results
No pathogenic variant detected
No mutation found in the analyzed exons. However, this does not rule out mutations in other regions or non-genetic causes.
Clinical recommendation: Consider further testing if clinical suspicion remains high.
Pathogenic variant detected
A disease-causing mutation is present. This confirms the genetic basis of the condition.
Clinical recommendation: Proceed with clinical management, including prophylactic surgery if indicated, and offer family screening.
Variant of uncertain significance (VUS)
A genetic variant was found, but its impact on health is not yet known.
Clinical recommendation: Further segregation analysis and functional studies may be needed. Genetic counseling is advised.
Consult your doctor if you have symptoms suggestive of MEN2, MTC, or pheochromocytoma, such as neck mass, hoarseness, difficulty swallowing, high blood pressure, or family history of these conditions. Early genetic testing can guide preventive measures.
Limitations
- ⚠This test only covers exons 5, 8, 10, 11, and 13-16; mutations in other exons or regulatory regions will not be detected.
- ⚠Large deletions/duplications may not be identified by sequencing alone.
- ⚠Variant interpretation may be limited by current knowledge; variants of uncertain significance may be reported.
- ⚠Not a substitute for full gene sequencing or whole exome sequencing.
- ⚠Results should be interpreted in the context of clinical and family history.
Risks & Considerations
- ●Minimal risk of bruising or infection at the blood draw site
- ●Psychological impact of learning genetic risk
- ●Potential for incidental findings
- ●Insurance or employment discrimination concerns (mitigated by laws in some regions)
Interfering Factors
- ●Contamination of sample with foreign DNA
- ●Degraded DNA due to improper storage or transport
- ●Presence of hematologic malignancies causing clonal hematopoiesis
- ●Recent blood transfusion (for blood samples)
- ●Insufficient DNA quantity or quality
Compare With Similar Tests
| Test | RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic Test | Full RET Gene Sequencing | RET Gene Deletion/Duplication Analysis | Multi-Gene Cancer Panel |
|---|---|---|---|---|
| Comparison | RET Gene RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 NGS Genetic Test |
Frequently Asked Questions
What is the RET gene selective sequencing test?
Who should consider this test?
What is the cost of the test?
What sample is required?
Do I need to fast before the test?
How long does it take to get results?
Will I receive raw data files?
What does a positive result mean?
Can this test detect all RET mutations?
Is genetic counseling included?
Is the test available across India?
What is the turnaround time for home collection?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.